NAUT compared with KPRX: revenue, margins and what each company keeps, and the suppliers and customers both name

NAUTNautilus Biotechnology, Inc.

Mkt capRevenueRevenue

KPRXKiora Pharmaceuticals Inc

Mkt capRevenueRevenue

Compare

NAUTNautilus Biotechnology, Inc.

KPRXKiora Pharmaceuticals Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

NAUT2 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±25.3%▲+18.44%×0.73

Q2 FY26—▼−27.71%—

KPRX1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▲+3.13%—

= impliedNAUT realized, solidKPRX realized, hatchedOne scale, both sides: full bar = 28%× = |realized| ÷ impliedSource: market data

NAUTNautilus Biotechnology, Inc.

2.74▼−12.74%· post 2.73

Mkt cap$347.7MRevenue$234,000Q3 FY26

KPRXKiora Pharmaceuticals Inc

1.58▼−10.50%· post 1.58

ClosedOct 30 '26

Mkt cap$6.9MRevenue$20,000Q2 FY24

Compare

ClosedOct 30 '26

NAUTNautilus Biotechnology, Inc.

KPRXKiora Pharmaceuticals Inc

2.74▼−12.74%post 2.73

Price

1.58▼−10.50%post 1.58

$347.7M

Mkt cap

$6.9M

Q3 FY26$234,000

Revenue

$20,000Q2 FY24

NAUT2.74▼−12.74%vsKPRX1.58▼−10.50%ClosedOct 30 '26